No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Pharmaceuticals
Parmax Pharma Limited primarily manufactures active pharmaceutical ingredients (APIs), including ampicillin, amoxicillin, cephalexin, and nalidixic acid. The company also intends to expand its activities into the formulation of finished dosage forms such as tablets, capsules, ointments, and injectables. Established on November 2, 1994, the firm's corporate headquarters are located in Rajkot, India.
www.parmaxpharma.comNo one on the platform currently holds PARMAX.BO.
No tracked institution reports a position in PARMAX.BO as of their last filing.
No one on the platform has traded PARMAX.BO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| PARMAX.BOParmax Pharma Limited | $135.05 | +0.97% | $505M | — |
| BERLDRG.BOBeryl Drugs Limited | $23.97 | +3.14% | $122M | — |
| CHCL.BOCian Healthcare Limited | $5.01 | +0.00% | $125M | — |
| COLINZ.BOColinz Laboratories Limited | $74.40 | -0.80% | $187M | — |
| DECIPHER.BODecipher Labs Ltd. | $5.80 | -3.01% | $59M | — |
| EMMESSA.BOEmmessar Biotech & Nutrition Limited | $24.60 | +4.24% | $123M | — |
| EVOQ.BOEvoq Remedies Ltd. | $1.49 | -0.67% | $37M | — |
Source: Financial Modeling Prep · peers by sector/industry